Tiered Pharmacy Copayments for Medications; Calendar Year 2022 Update, 74431-74432 [2021-28343]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 248 / Thursday, December 30, 2021 / Notices
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information.
Approved: December 27, 2021.
Jon R. Callahan,
Tax Analyst.
[FR Doc. 2021–28372 Filed 12–29–21; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Tiered Pharmacy Copayments for
Medications; Calendar Year 2022
Update
Department of Veterans Affairs.
Notice.
AGENCY:
ACTION:
This Department of Veterans
Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Mr.
Joseph Duran, Director of Policy and
Planning, Office of Community Care
(13BOA1), Veterans Health
Administration, 3773 Cherry Creek
North Drive, Denver, CO 80209, 303–
370–1637. This is not a toll-free
telephone number.
SUPPLEMENTARY INFORMATION: Section
17.110 of title 38, CFR, governs
copayments for medications that VA
provides to Veterans. Section 17.110
provides the methodologies for
establishing the copayment amount for
each 30-day or fewer supply of
medication provided by VA on an
outpatient basis (other than medication
administered during treatment).
SUMMARY:
Condition
Blood Thinners and .............................................
Platelet Inhibitors .................................................
Cholesterol ..........................................................
Dementia .............................................................
Diabetes ..............................................................
Electrolyte Supplement .......................................
Gastrointestinal Health ........................................
khammond on DSKJM1Z7X2PROD with NOTICES
Glaucoma and Eye Care .....................................
Heart Health and Blood Pressure .......................
VerDate Sep<11>2014
17:19 Dec 29, 2021
Tier 1 medication means a multisource medication that has been
identified using the process described in
paragraph (b)(2) of this section. Not less
than once per year, VA will identify a
subset of multi-source medications as
Tier 1 medications. Only medications
that meet all of the criteria in 38 CFR
17.110(b)(2)(i), (ii) and (iii) will be
eligible to be considered Tier 1
medications, and only those
medications that meet all of the criteria
in paragraph (b)(2)(i) of this section will
be assessed using the criteria in
paragraphs (b)(2)(ii) and (iii).
Based on the methodologies set forth
in § 17.110, this notice updates the list
of Tier 1 medications for Calendar Year
2022. The Tier 1 medication list is
posted on VA’s Community Care
website at the following link: https://
www.va.gov/COMMUNITYCARE/
revenue_ops/copays.asp under the
heading ‘‘Tier 1 Copay Medication
List.’’
The following table is the Tier 1
Copay Medication List that is effective
January 1, 2022, and will remain in
effect until December 31, 2022.
VA product name
Arthritis and Pain .................................................
Jkt 256001
Aspirin Buffered Tablet.
Aspirin Chewable Tablet.
Aspirin Enteric-Coated (EC) Tablet.
Allopurinol Tablet.
Celecoxib Capsule.
Diclofenac Tablet.
Ibuprofen Tablet.
Meloxicam Tablet.
Naproxen Tablet.
Clopidogrel Bisulfate Tablet.
Warfarin Sodium Tablet.
Atorvastatin Tablet.
Ezetimibe Tablet.
Pravastatin Tablet.
Rosuvastatin Calcium tablet.
Simvastatin Tablet.
Donepezil Tablet.
Glimepiride Tablet.
Glipizide Tablet.
Metformin Hydrochloride (HCL) Tablet.
Metformin HCL 24-Hour Sustained Action (SA) Tablet.
Pioglitazone HCL Tablet.
Potassium SA Tablet.
Potassium SA Dispersible Tablet.
Famotidine Tablet.
Omeprazole EC Capsule.
Pantoprazole Sodium EC Capsule.
Psyllium Mucilloid.
Diclofenac Solution.
Dorzolamide 2%/Timolol 0.5% Solution.
Latanoprost 0.005% Solution.
Carboxymethylcellulose Sodium Solution.
Amlodipine Tablet. Aspirin (see Arthritis & Pain).
Atenolol Tablet.
Carvedilol Tablet.
Chlorthalidone Tablet.
Clonidine Tablet.
Digoxin Tablet.
Diltiazem 24-Hour Capsule.
Diltiazem HCL Tablet.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
74431
E:\FR\FM\30DEN1.SGM
30DEN1
74432
Federal Register / Vol. 86, No. 248 / Thursday, December 30, 2021 / Notices
Condition
VA product name
Mental Health ......................................................
Neurologic Disorders ...........................................
Respiratory Condition ..........................................
Seizures ..............................................................
Thyroid Conditions ..............................................
Urologic (Bladder and Prostate) Health ..............
Signing Authority
The Secretary of Veterans Affairs,
approved this document on December
14, 2021, and authorized the
Furosemide Tablet.
Hydralazine HCL Tablet.
Hydrochlorothiazide Tablet/Capsule.
Hydrochlorothiazide/Lisinopril Tablet.
Hydrochlorothiazide/Losartan Tablet.
Hydrochlorothiazide/Triamterene Tablet/Capsule.
Isosorbide Mononitrate SA Tablet.
Lisinopril Tablet.
Losartan Tablet.
Metoprolol Succinate SA Tablet.
Metoprolol Tartrate Tablet.
Nifedipine SA Capsule.
Nitroglycerin Sublingual Tablet.
Prazosin HCL Capsule.
Propranolol HCL Tablet.
Spironolactone Tablet.
Amitriptyline HCL Tablet.
Buspirone HCL Tablet.
Bupropion HCL Tablet.
Bupropion HCL SA (12-HR-SR) Tablet.
Bupropion HCL SA (24-HR-XL) Tablet.
Citalopram Hydrobromide Tablet.
Duloxetine HCL EC Capsule.
Escitalopram Oxalate Tablet.
Fluoxetine Tablet/Capsule.
Mirtazapine Tablet.
Olanzapine Immediate Release (IR) Tablet.
Paroxetine Tablet.
Sertraline HCL Tablet.
Trazodone Tablet.
Venlafaxine HCL IR Tablet.
Venlafaxine HCL SA Capsule.
Ropinirole IR Tablet.
Montelukast Sodium Tablet.
Gabapentin Capsule.
Lamotrigine Tablet.
Topiramate Tablet.
Levothyroxine Sodium Tablet.
Doxazosin Mesylate Tablet. Finasteride Tablet.
Oxybutynin Chloride IR tablet.
Oxybutynin Chloride SA tablet.
Sildenafil Tablet.
Tadalafil Tablet.
Tamsulosin HCL Capsule.
Terazosin HCL Capsule.
undersigned to sign and submit the
document to the Office of the Federal
Register for publication electronically as
an official document of the Department
of Veterans Affairs.
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy
& Management, Office of General Counsel,
Department of Veterans Affairs.
[FR Doc. 2021–28343 Filed 12–29–21; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 8320–01–P366
VerDate Sep<11>2014
17:19 Dec 29, 2021
Jkt 256001
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 86, Number 248 (Thursday, December 30, 2021)]
[Notices]
[Pages 74431-74432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28343]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications; Calendar Year 2022
Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Mr. Joseph Duran, Director of Policy
and Planning, Office of Community Care (13BOA1), Veterans Health
Administration, 3773 Cherry Creek North Drive, Denver, CO 80209, 303-
370-1637. This is not a toll-free telephone number.
SUPPLEMENTARY INFORMATION: Section 17.110 of title 38, CFR, governs
copayments for medications that VA provides to Veterans. Section 17.110
provides the methodologies for establishing the copayment amount for
each 30-day or fewer supply of medication provided by VA on an
outpatient basis (other than medication administered during treatment).
Tier 1 medication means a multi-source medication that has been
identified using the process described in paragraph (b)(2) of this
section. Not less than once per year, VA will identify a subset of
multi-source medications as Tier 1 medications. Only medications that
meet all of the criteria in 38 CFR 17.110(b)(2)(i), (ii) and (iii) will
be eligible to be considered Tier 1 medications, and only those
medications that meet all of the criteria in paragraph (b)(2)(i) of
this section will be assessed using the criteria in paragraphs
(b)(2)(ii) and (iii).
Based on the methodologies set forth in Sec. 17.110, this notice
updates the list of Tier 1 medications for Calendar Year 2022. The Tier
1 medication list is posted on VA's Community Care website at the
following link: https://www.va.gov/COMMUNITYCARE/revenue_ops/copays.asp
under the heading ``Tier 1 Copay Medication List.''
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2022, and will remain in effect until December 31,
2022.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain................ Aspirin Buffered Tablet.
Aspirin Chewable Tablet.
Aspirin Enteric-Coated (EC) Tablet.
Allopurinol Tablet.
Celecoxib Capsule.
Diclofenac Tablet.
Ibuprofen Tablet.
Meloxicam Tablet.
Naproxen Tablet.
Blood Thinners and................ Clopidogrel Bisulfate Tablet.
Platelet Inhibitors............... Warfarin Sodium Tablet.
Cholesterol....................... Atorvastatin Tablet.
Ezetimibe Tablet.
Pravastatin Tablet.
Rosuvastatin Calcium tablet.
Simvastatin Tablet.
Dementia.......................... Donepezil Tablet.
Diabetes.......................... Glimepiride Tablet.
Glipizide Tablet.
Metformin Hydrochloride (HCL)
Tablet.
Metformin HCL 24-Hour Sustained
Action (SA) Tablet.
Pioglitazone HCL Tablet.
Electrolyte Supplement............ Potassium SA Tablet.
Potassium SA Dispersible Tablet.
Gastrointestinal Health........... Famotidine Tablet.
Omeprazole EC Capsule.
Pantoprazole Sodium EC Capsule.
Psyllium Mucilloid.
Glaucoma and Eye Care............. Diclofenac Solution.
Dorzolamide 2%/Timolol 0.5%
Solution.
Latanoprost 0.005% Solution.
Carboxymethylcellulose Sodium
Solution.
Heart Health and Blood Pressure... Amlodipine Tablet. Aspirin (see
Arthritis & Pain).
Atenolol Tablet.
Carvedilol Tablet.
Chlorthalidone Tablet.
Clonidine Tablet.
Digoxin Tablet.
Diltiazem 24-Hour Capsule.
Diltiazem HCL Tablet.
[[Page 74432]]
Furosemide Tablet.
Hydralazine HCL Tablet.
Hydrochlorothiazide Tablet/Capsule.
Hydrochlorothiazide/Lisinopril
Tablet.
Hydrochlorothiazide/Losartan Tablet.
Hydrochlorothiazide/Triamterene
Tablet/Capsule.
Isosorbide Mononitrate SA Tablet.
Lisinopril Tablet.
Losartan Tablet.
Metoprolol Succinate SA Tablet.
Metoprolol Tartrate Tablet.
Nifedipine SA Capsule.
Nitroglycerin Sublingual Tablet.
Prazosin HCL Capsule.
Propranolol HCL Tablet.
Spironolactone Tablet.
Mental Health..................... Amitriptyline HCL Tablet.
Buspirone HCL Tablet.
Bupropion HCL Tablet.
Bupropion HCL SA (12-HR-SR) Tablet.
Bupropion HCL SA (24-HR-XL) Tablet.
Citalopram Hydrobromide Tablet.
Duloxetine HCL EC Capsule.
Escitalopram Oxalate Tablet.
Fluoxetine Tablet/Capsule.
Mirtazapine Tablet.
Olanzapine Immediate Release (IR)
Tablet.
Paroxetine Tablet.
Sertraline HCL Tablet.
Trazodone Tablet.
Venlafaxine HCL IR Tablet.
Venlafaxine HCL SA Capsule.
Neurologic Disorders.............. Ropinirole IR Tablet.
Respiratory Condition............. Montelukast Sodium Tablet.
Seizures.......................... Gabapentin Capsule.
Lamotrigine Tablet.
Topiramate Tablet.
Thyroid Conditions................ Levothyroxine Sodium Tablet.
Urologic (Bladder and Prostate) Doxazosin Mesylate Tablet.
Health. Finasteride Tablet.
Oxybutynin Chloride IR tablet.
Oxybutynin Chloride SA tablet.
Sildenafil Tablet.
Tadalafil Tablet.
Tamsulosin HCL Capsule.
Terazosin HCL Capsule.
------------------------------------------------------------------------
Signing Authority
The Secretary of Veterans Affairs, approved this document on
December 14, 2021, and authorized the undersigned to sign and submit
the document to the Office of the Federal Register for publication
electronically as an official document of the Department of Veterans
Affairs.
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy & Management, Office of
General Counsel, Department of Veterans Affairs.
[FR Doc. 2021-28343 Filed 12-29-21; 8:45 am]
BILLING CODE 8320-01-P366
